Bluebird Bio revised its agreement with Carlyle and SK Capital, adding a $5 per share cash option for stockholders ahead of deal completion.
Bluebird Bio Shareholders Get New All-Cash Offer From Private Equity
Where Today's News Shapes Tomorrow
February 20, 2026
Headlines
